Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin

Bone Marrow Transplantation

Volumn 25, Issue , 2000, Pages S88-S95

  Delp, K ^a   Momburg, F ^b   Hilmes, C ^a   Huber, C ^a   Seliger, B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Chaperones; Ifn ; Mhc class 1; Peptide transporter; Proteasome

Indexed keywords

BETA 2 MICROGLOBULIN; CALNEXIN; CALRETICULIN; HLA A ANTIGEN; HLA B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; RAS PROTEIN; TAPASIN;

CONFERENCE PAPER; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CYSTEINE ENDOPEPTIDASES; DNA PRIMERS; GENE EXPRESSION; GENES, RAS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON-GAMMA, RECOMBINANT; MICE; MULTIENZYME COMPLEXES; MUTATION; NEOPLASMS, GLANDULAR AND EPITHELIAL; PROTEINS; TUMOR CELLS, CULTURED;

EID: 0033945925     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702363     Document Type: Article

References (30)

1. Zinkernagel RM, Doherty PC. MHC restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction specificity, function and responsiveness. Adv Immunol 1979; 27: 51-77.
2. Rötzschke O, Falk K, Deres K et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 1990; 348: 252-254.
3. Belich MP, Glynne RJ, Senger G et al. Proteasome compo nents with reciprocal expression to that of the MHC-encoded LMP proteins. Curr Biol 1994; 4: 769-776.
4. Nandi D, Jiang H, Monaco JJ. Identification of MECL-1 (LMP-10) as the third IFN-g-inducible proteasome subunit. J Immunol 1996; 156: 2361-2364.
5. Ortiz-Navarette V, Seeling A, Gernold M et al. Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex. Nature 1991; 353: 663-665.
6. Groettrup M, Ruppert T, Kuehn L et al. The interferon-ginducible S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro. J Biol Chem 1995; 270: 23808-23815.
7. Trowsdale J, Hanson I, Mockridge I et al. Sequence encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature 1990; 348: 741-744.
8. Spies T, Bresnahan M, Bahram S et al. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 1990; 348: 744-747.
9. Li S, Sjögren H-O, Hellman U et al. Cloning and functional characterization of a subunit of the transporter associated with antigen processing. Proc Natl Acad Sci USA 1997; 94: 8708-8713.
10. Sadasivan B, Lehner PJ, Ortmann B et al. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996; 5: 103-114.
11. Ortmann B, Copeman J, Lehner PJ et al. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 1997; 277: 1306-1309.
12. Momburg F, Ortiz-Navarette V, Neefjes J et al. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature 1992; 360: 174-177.
13. Sibille C, Gould KG, Willard-Gallo K et al. LMP21 proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes. Curr Biol 1995; 5: 923-930.
14. Lehner PJ, Surman MJ, Cresswell P. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line. Immunity 1998; 8: 221-231.
15. van Kaer L, Ashton-Rickardt P, Ploegh H et al. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules and CD4-CD81 T cells. Cell 1992; 71: 1205-1214.
16. Fehling HJ, Swat W, Laplace C et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 1994; 265: 1234-1237.
17. Restifo NP, Esquivel F, Kawakami Y et al. Identification of human cancers deficient in antigen processing. J Exp Med 1993; 177: 265-272.
18. Cromme FV, Airey J, Heemels MT et al. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med 1994; 179: 335-340.
19. Seliger B, Maeurer MJ, Ferrone S. TAP off-tumors on. Immunol Today 1997; 18: 292-299.
20. Seliger B, Höhne A, Knuth A et al. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression. Clin Cancer Res 1996; 2: 1427-1433.
21. Johnssen A, France J, Sy M-S et al. Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines. Cancer Res 1998; 58: 3660-3667.
22. Seliger B, Harders C, Lohmann S et al. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts. Eur J Immunol 1998; 28: 122-133.
23. Salter RD, Howell DN, Cresswell P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 1985; 21: 235-246.
24. Neumann E, Engelsberg A, Decker J et al. Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glyprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies? Cancer Res 1998; 58: 4090-4095.
25. Neefjes JJ, Momburg F, Hämmerling GJ. Selective and ATPdependent translocation of peptides by MHC-encoded transporter. Science 1993; 261: 769-771.
26. Ljunggren HG, Stam NJ, ö hlen C et al. Empty MHC class I molecules come out in the cold. Nature 1990; 346: 476-480.
27. Epperson DE, Arnold D, Spies T et al. Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. J Immunol 1992; 149: 3297-3301.
28. Wright K, White LC, Kelly A et al. Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J Exp Med 1995; 181: 1459-1471.
29. Neefjes J, Gottfried E, Roelse J et al. Analysis of the fine specificity of rat, mouse and human TAP peptide transporters. Eur J Immunol 1995; 25: 1133-1136.
30. Korkolopoulou P, Kaklamanis L, Pezzella F et al. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br J Cancer 1996; 73: 148-153.